Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4M Buy
105,134
+1,096
+1% +$39K 0.08% 231
2026
Q1
$3.12M Buy
104,038
+1,335
+1% +$42.4K 0.07% 264
2025
Q4
$3M Buy
102,703
+51,282
+100% +$1.36M 0.06% 265
2025
Q3
$1.34M Sell
51,421
-14,864
-22% -$369K 0.04% 331
2025
Q2
$1.49M Buy
66,285
+37,400
+129% +$768K 0.05% 318
2025
Q1
$603K Sell
28,885
-12,550
-30% -$263K 0.05% 287
2024
Q4
$880K Buy
+41,435
New +$908K 0.06% 278

Other funds holding IX

Callan Family Office's IX Position: Q2 2026 in Review

Callan Family Office increased its ORIX (IX) stake by 1.1% in Q2 2026, buying an estimated $39K and bringing the position to 105,134 shares worth $4M. The position accounts for 0.08% of the portfolio, ranked #231.

Callan Family Office first reported a position in IX in Q4 2024 and has held it in 7 quarters since. 320 funds tracked by Wall St. Rank hold IX as of Q2 2026.

  • Callan Family Office held 105,134 shares of ORIX worth $4M as of Q2 2026.
  • Callan Family Office bought 1,096 ORIX shares in Q2 2026, an estimated $39K.
  • ORIX made up 0.08% of Callan Family Office's portfolio in Q2 2026, its #231 holding.
  • Callan Family Office first reported a position in ORIX in Q4 2024 and has held it in 7 quarters since.
  • 320 funds tracked by Wall St. Rank held ORIX as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.